- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02448498
Strength Training Regimen for Normal Weight Diabetics (STRONG-D)
April 7, 2021 updated by: Latha Palaniappan, MD, MS, Stanford University
The Strength Training Regimen in Normal Weight Diabetics (STRONG-D) study will examine the effectiveness of different exercise regimen types in controlling diabetes for the normal weight type 2 diabetes population.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In the STRONG-D study, participants are randomly assigned to strength training, aerobic training or a combined strength and aerobic training group.
Participants in the exercise group will attend exercise sessions over the course of 9 months at the YMCA.
Participants will have opportunities to engage in other activities such as educational run-in visits that will allow for measurement of hemoglobin A1c and emphasize the importance of exercise in improving Type 2 diabetes.
Study Type
Interventional
Enrollment (Actual)
289
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Palo Alto, California, United States, 94304
- Stanford
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Recent hemoglobin A1c result between 6.5%-13%
- Diagnosis of Type 2 Diabetes Mellitus
- BMI between 18.5 -25 kg/m2
- Blood pressure < 160/100
- Sedentary lifestyle
- Able and willing to enroll and meet requirements of the study
Exclusion Criteria:
- Age less than 30 years or greater than 75 years
- Type 1 diabetes or use of insulin pump
- Triglycerides >500 mg/dL
- Use of weight loss medication
- Bariatric surgery
- Consumes >14 alcoholic drinks per week
- Pregnancy
- Plans to be away for more than four weeks
- Medical conditions which would prevent long-term participation or which would contraindicate physical activity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Strength Training Only
Participants in the strength-training only group will take part in a 9-month exercise intervention at a local exercise facility.
They will engage in strength training 3 days per week for approximately 60 minutes each exercise session.
|
|
|
Experimental: Aerobic Training Only
Participants in the aerobic training only group will take part in a 9-month exercise intervention at a local exercise facility.
They will engage in aerobic training over 3 -5 days per week to achieve the targeted dose of 12 kcal/kg per week at a training intensity between 50-80% VO2 max.
|
|
|
Experimental: Combination (Strength and Aerobic) Training
Participants in the combination (strength and aerobic training) group will take part in a 9-month exercise intervention at a local exercise facility.
They will engage aerobic training that will expend 10 kcal/kg/week in combination with strength-training, 3 days per week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Hemoglobin A1c across study visits
Time Frame: Baseline, monthly (for 9 months), 9-Months
|
Baseline, monthly (for 9 months), 9-Months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in body composition across study visits, as measured using DEXA
Time Frame: Baseline, 9-Months
|
Baseline, 9-Months
|
|
Change in waist circumference across study visits
Time Frame: Baseline, 9-Months
|
Baseline, 9-Months
|
|
Change in blood pressure across study visits
Time Frame: Baseline, 9-Months
|
Baseline, 9-Months
|
|
Change in body weight across study visits
Time Frame: Baseline, 9-Months
|
Baseline, 9-Months
|
|
Changes in cardiorespiratory fitness, as measured by 6-minute walk test
Time Frame: Baseline, 9-Months
|
Baseline, 9-Months
|
|
Change in muscle strength and endurance, as measured by Biodex strength testing
Time Frame: Baseline, 9-Months
|
Baseline, 9-Months
|
|
Change in quality of life
Time Frame: Baseline, 9-Months
|
Baseline, 9-Months
|
|
Change in Dietary Intake, as measured by Food Frequency Questionnaire
Time Frame: Baseline, 9-Months
|
Baseline, 9-Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Latha Palaniappan, MD, MS, Stanford School of Medicine
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2016
Primary Completion (Actual)
July 1, 2020
Study Completion (Actual)
July 1, 2020
Study Registration Dates
First Submitted
March 6, 2015
First Submitted That Met QC Criteria
May 14, 2015
First Posted (Estimate)
May 19, 2015
Study Record Updates
Last Update Posted (Actual)
April 12, 2021
Last Update Submitted That Met QC Criteria
April 7, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 32113
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
State University of New York at BuffaloMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Medtronic MiniMed, Inc.RecruitingType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States, Australia, New Zealand
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
Clinical Trials on Exercise Intervention
-
VA Office of Research and DevelopmentRecruitingMobility Impairment | Asymptomatic Carotid Stenosis (50-69%)United States
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
University of AarhusRecruiting
-
Glasgow Caledonian UniversityUnknown
-
Turku University HospitalUniversity of Turku; University of Helsinki; Academy of Finland; European Foundation... and other collaboratorsUnknownType 2 Diabetes Mellitus | Healthy VolunteersFinland
-
Hacettepe UniversityHacettepe University Scientific Research Projects Coordination UnitNot yet recruitingSubstrate Oxidation | Postprandial Metabolism | Exercise Physiology | Cardiovascular Risk MarkersTurkey (Türkiye)
-
Medipol UniversityCompleted
-
University Medical Center GroningenDutch Kidney Foundation; Innovation Fund of the Dutch Medical Insurance CompaniesCompletedMetabolic Syndrome | Kidney Transplant | Post-transplant Weight GainNetherlands
-
Istanbul UniversityCompletedGlenohumeral ArthritisTurkey
-
Aristotle University Of ThessalonikiCompleted